Using GLP-1 short term without addressing the eating patterns that will need to sustain weight loss independently is unlikely to produce lasting results
Risks and Unknowns Remaining research gaps include: Long-term systemic administration data Optimal dosing strategies outside dermatology Interaction with copper metabolism disorders Comparative efficacy versus standard wound treatments Most evidence supports local, tissue specific effects rather than systemic transformation
Other wellness boosts may feel more gradual, but rest assured that youre doing your body a big favor with your IV therapy
Our providers closely monitor your response to the medication, adjusting your treatment plan as needed to help you achieve your health and weight loss goals safely and effectively
Request a DEXA scan at baseline and 12 weeks to track lean mass changes, or use bioelectrical impedance analysis (BIA) if DEXA isn't accessible
However, despite strong epidemiological and mechanistic evidence linking obesity-induced OS to endometrial diseases, clinical direct evidence remains insufficient and its clinical application is relatively limited